Skip to main content

Find Clinical Trials

Home
Conditions
Multiple Myeloma

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,662 public trials 323 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

Role of BCL-B in Multiple Myeloma

NCT01270009

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Service de Médecine interne et cancérologie - Hôpital de l'Archet Nice, France

View Trial Details

Completed

A Single-centre Prospective Study to Explore the Role of Frailty in Patients With Multiple Myeloma.

NCT04683393

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Subcutaneous Velcade Plus Oral Melphalan and Prednisone or Plus Cycloposphamide and Prednisone or Plus Prednisone

NCT01190787

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease, +15 more
Locations: A.O.U. Città della Salute e della Scienza di Torino - SC Ematologia U Torino, Italy

View Trial Details

Completed

Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients

NCT01394640

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +17 more
Locations: Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy

View Trial Details

Completed

Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile

NCT01454297

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Mayo Clinic Campus in Scottsdale, AZ Scottsdale, Arizona, United States

UC San Diego Moores Cancer Center San Diego, California, United States

Sharp Health Care San Diego, California, United States

VA San Diego Healthcare System San Diego, California, United States

View all 73 locations

View Trial Details

Completed

COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies

NCT05028374

Conditions: AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +28 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Uproleselan (GMI-1271) for GI Toxicity Prophylaxis During Melphalan-Conditioned Autologous Hematopoietic Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM)

NCT04682405

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Role of18F-FDG PET-CT for Assessing and Predicting Response to Daratumumab and for Prognosis With Multiple Myeloma

NCT06170151

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Irccs San Raffaele Milan, Italia, Italy

View Trial Details

Completed

Maintenance Therapy With Subcutaneous Bortezomib

NCT01913730

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Irccs Crob Rionero in Vulture, Potenza, Italy

View Trial Details

Completed

Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma

NCT01421524

Conditions: Adenocarcinoma, Astrocytoma, Blood Protein Disorders, +35 more
Locations: City of Hope Cancer Center Duarte, California, United States

UCLA Neuro-Oncology Program Los Angeles, California, United States

UCSF Helen Diller Medical Center at Parnassus Heights San Francisco, California, United States

University Of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

View all 39 locations

View Trial Details